PubMed:32338224 / 10191-10323 JSONTXT

{"project":"LitCovid-OGER-BB","denotations":[{"id":"T303","span":{"begin":113,"end":121},"obj":"SP_7"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"Contemporarily, Danser and associates [51] claim that there is no evidence to stop RAS blockers in the course of COVID-19 infection."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T26","span":{"begin":83,"end":86},"obj":"Body_part"}],"attributes":[{"id":"A26","pred":"uberon_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/UBERON_0018229"}],"text":"Contemporarily, Danser and associates [51] claim that there is no evidence to stop RAS blockers in the course of COVID-19 infection."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T60","span":{"begin":113,"end":121},"obj":"Disease"},{"id":"T61","span":{"begin":122,"end":131},"obj":"Disease"}],"attributes":[{"id":"A60","pred":"mondo_id","subj":"T60","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A61","pred":"mondo_id","subj":"T61","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Contemporarily, Danser and associates [51] claim that there is no evidence to stop RAS blockers in the course of COVID-19 infection."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T64","span":{"begin":83,"end":86},"obj":"Chemical"}],"attributes":[{"id":"A64","pred":"chebi_id","subj":"T64","obj":"http://purl.obolibrary.org/obo/CHEBI_63620"}],"text":"Contemporarily, Danser and associates [51] claim that there is no evidence to stop RAS blockers in the course of COVID-19 infection."}

{"project":"PubMed_ArguminSci","denotations":[{"id":"T63","span":{"begin":0,"end":132},"obj":"DRI_Background"}],"text":"Contemporarily, Danser and associates [51] claim that there is no evidence to stop RAS blockers in the course of COVID-19 infection."}

{"project":"LitCovid-sentences","denotations":[{"id":"T63","span":{"begin":0,"end":132},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Contemporarily, Danser and associates [51] claim that there is no evidence to stop RAS blockers in the course of COVID-19 infection."}